Novo Nordisk A/S
NVO• NYSE
$50.32
-1.16-2.25%
In the past 24 hours
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: December 2025 · 2025-12-31
Revenue
$79.14B
Net income
$26.89B
Free cash flow
-$36.22B
Diluted EPS
—
Gross margin
80.86%
Profit margin
33.98%
Assets
$542.90B
Cash
$26.46B
Valuation
Market Cap$182.56B
Enterprise Value$199.31B
PE (TTM)2.19
PE (Fwd)12.24
Price to Sales0.59
EV / EBITDA8.12
Price to Book1.15
PEG Ratio4.53
Cash Flow
FCF Yield15.88%
FCF / Share$6.52
SBC-Adj FCF Yield—
SBC-Adj FCF / Share$6.52
SBC Impact—
Margins & Growth
Gross Margin80.98%
Operating Margin41.30%
Profit Margin33.14%
Quarterly Rev YoY-7.63%
Quarterly EPS YoY-4.74%
Balance
Cash$26.46B
Debt$130.96B
Net Debt$104.49B
Current Ratio0.80
Debt / Equity67.49
Dividend
Dividend Yield23.40%
Payout Ratio51.12%
DPS (TTM)$11.77
Last Ex-Date2026-03-30
Dividend history
Cash dividends by ex-date, not an investment recommendation.
Trailing 12 months
$1.86
Latest dividend
$1.28 · Mar 30, 2026
First record
Apr 23, 1982
Next ex-date
—
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Mar 30, 2026 | $1.28 | Apr 8, 2026 | Semiannual |
| Aug 18, 2025 | $0.58 | Aug 26, 2025 | Semiannual |
| Mar 31, 2025 | $1.10 | Apr 8, 2025 | Semiannual |
| Aug 16, 2024 | $0.51 | Aug 26, 2024 | Semiannual |
| Mar 22, 2024 | $0.93 | Apr 2, 2024 | Semiannual |
| Aug 18, 2023 | $0.44 | Aug 29, 2023 | Semiannual |
| Mar 24, 2023 | $0.59 | Apr 4, 2023 | Semiannual |
| Aug 12, 2022 | $0.29 | Aug 23, 2022 | Semiannual |
| Mar 25, 2022 | $0.52 | Apr 5, 2022 | Semiannual |
| Aug 16, 2021 | $0.28 | Aug 25, 2021 | Semiannual |
| Mar 26, 2021 | $0.47 | Apr 7, 2021 | Semiannual |
| Aug 14, 2020 | $0.26 | Aug 25, 2020 | Semiannual |
| Mar 27, 2020 | $0.39 | Apr 7, 2020 | Semiannual |
| Aug 16, 2019 | $0.22 | Aug 27, 2019 | Semiannual |
| Mar 22, 2019 | $0.39 | Apr 2, 2019 | Semiannual |
| Aug 17, 2018 | $0.23 | Aug 28, 2018 | Semiannual |
| Mar 23, 2018 | $0.34 | Apr 3, 2018 | Semiannual |
| Aug 17, 2017 | $0.24 | Aug 29, 2017 | Annual |
| Mar 23, 2017 | $0.33 | Apr 4, 2017 | Annual |
| Aug 11, 2016 | $0.22 | Aug 23, 2016 | Annual |
| Mar 18, 2016 | $0.48 | Mar 30, 2016 | Annual |
| Mar 19, 2015 | $0.38 | Mar 31, 2015 | Annual |
| Mar 21, 2014 | $0.42 | Apr 2, 2014 | Annual |
| Mar 21, 2013 | $0.32 | Apr 2, 2013 | Annual |
Price
+26.73%
Jul 19, 2021 - Jul 17, 2026 · 1,244 daily points
Revenue
↑ 133.6%Net Income
↑ 126.0%Free Cash Flow
↓ 536.9%Diluted EPS
No data
Quick Stats
Open
$51.06
Day High
$51.40
Day Low
$50.00
Prev Close
$51.48
Market Cap
—
Volume
9,539,400
Novo Nordisk A/S (NVO) analysis
Wrqti brings Novo Nordisk A/S data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Available price
$50.32
Market cap
$182.56B
PE ratio
2.19
Price to book
1.15
Profit margin
33.14%
FCF yield
15.88%
Stocks related to Novo Nordisk A/S
Companies in the same sector you can compare with Novo Nordisk A/S: